Innovasis, Inc. – Trademark Portfolio
Entity Type: 03
Innovasis, Inc. holds 88 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 83 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. Currently, 37 trademarks are registered and 6 are pending. Notable registered marks include AX, CX, PX, TX, and AXHA. The owner is based in Salt Lake City, UT.
614 East 3900 South
Innovasis, Inc.
Salt Lake City, UT 84107
Showing of trademarks Trademarks
Trademark Classifications
Innovasis, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Innovasis, Inc. have?
Innovasis, Inc. has 88 U.S. trademarks filed with the USPTO. Of these, 37 registered, 6 pending, 45 abandoned.
What trademark classes does Innovasis, Inc. file in?
Innovasis, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Innovasis, Inc.'s most well-known trademarks?
Innovasis, Inc.'s registered trademark portfolio includes well-known marks such as AX, CX, PX, TX, and AXHA. These are among 37 currently registered trademarks in the portfolio.
What is Innovasis, Inc.'s trademark registration success rate?
Innovasis, Inc. has a 45% trademark registration rate, with 37 out of 82 resolved applications resulting in successful registration. Currently, 6 applications are pending review.